Compliance
This section focuses on health care compliance and regulations – both national and state – including the ACA. It includes changes in health care law, regulation, and court decisions and their impact on health insurance professionals, employers, and individuals.
The trial starts Monday in the Justice Department’s challenge to health insurer Anthem Inc.’s $48 billion acquisition of reluctant partner Cigna Corp., a case that could produce unusual courtroom drama and be a last hurrah for President Barack Obama’s antitrust enforcers.
Donald Trump and his congressional allies are making big plans to repeal the Affordable Care Act and overhaul other government health programs.
President-elect Donald Trump says he wants to preserve health insurance coverage even as he pursues repeal of the Obama-era overhaul that provided it to millions of uninsured people.
Six years into building its business around the Affordable Care Act, the nation’s $3 trillion health care industry may be losing that political playbook.
It was all hands on deck at Covered California’s monthly board meeting Thursday as leaders of the state insurance exchange and a panel of experts spent hours trying to divine a health care world according to President-elect Donald Trump.
The Internal Revenue Service today reminded employers and small businesses of a new Jan. 31 filing deadline for Forms W-2. The IRS must also hold some refunds until Feb. 15.
House Speaker Paul D. Ryan said Thursday that Medicare has “serious problems” that would need to be addressed when Congress moves to repeal and replace President Obama’s health-care reform law — a signal that he is willing to immediately enter the treacherous politics of entitlement reform and perhaps break with President-elect Donald Trump.
Donald Trump’s victory in Tuesday’s presidential election, together with the defeat of a California ballot measure, has one industry breathing a sigh of relief, at least for now: pharmaceuticals.
And you thought the inflation rate was low.
Americans' growing alarm over rising prescription drug costs will pressure a new U.S. administration and Congress to take action on pharmaceutical pricing, industry executives and healthcare experts say.